Kim J,Peng D,Schlebach J,et al.Modest effects of lipid modification on the structure of caveolin-3[J].Biochemistry,2014,53(27):4 320-4 322.
[2]
Panneerselvam M,Patel H,Roth D,et al.Caveolins and heart diseases[J].Adv Exp Med Biol,2012,729:145-156.
[3]
Feron O,Balligand JL.Caveolins and the regulation of endothelial nitric oxide synthase in the heart[J].Cardiovasc Res,2006,69(4):788-797.
[4]
Lei S,Li H,Xu J,et al.Hyperglycemia-induced protein kinase Cβ2activation induced diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3expression and Akt/eNOS signaling[J].Diabetes,2013,62(7):2 318-2 328.
[5]
Trachanas K,Sideris S,Aggeli C,et al.Diabetic Cardiomyopath:From Pathophysiology to Treatment[J].Hellenic Journal of Cardiology,2014,55(5):411-421.
[6]
Liu Y,Lei S,Gao X,et al.PKCβinhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes[J].Clinical Science,2012,122(4):161-173.
[7]
Mao X,Wang T,Liu Y,et al.N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α/HO-1signaling in diabetic rats[J].PLoS One,2013,8(7):e68949.
[8]
Lei S,Liu Y,Liu H,et al.Efffects of N-acetylcysteine on nicotinamide dinucleotide phosphate oxidase activation and antioxidant status in heart,lung,liver and kidney in streptozotocin-induce diabetic rats[J].Yonsei Med J,2012,53(2):294-303.
[9]
Yang Y,Ma Z,Hu W,et al.Caveolin-1/-3:therapeutic targets for myocardial ischemia/reperfusion injury[J].Basic Res Cardiol,2016,111(4):45.
